|
Market Closed -
NYSE
16:00:03 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 18.61 USD | +1.20% |
|
-3.87% | -21.91% |
| 10-22 | Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell | MT |
| 10-21 | Wedbush Adjusts Price Target on Arcus Biosciences to $49 From $43, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Other Biotechnology & Medical Research | +1.20% | -3.87% | -21.91% | -8.28% | -44.35% | 2.64B |  | | |
- Stock Market
- Stocks
- RCUS Stock
- Charts Arcus Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
